• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑腱黄瘤病(CTX):荷兰患者群体的临床调查

Cerebrotendinous xanthomatosis (CTX): a clinical survey of the patient population in The Netherlands.

作者信息

Waterreus R J, Koopman B J, Wolthers B G, Oosterhuis H J

机构信息

Department of Neurology, University Hospital, Groningen, The Netherlands.

出版信息

Clin Neurol Neurosurg. 1987;89(3):169-75. doi: 10.1016/s0303-8467(87)80050-1.

DOI:10.1016/s0303-8467(87)80050-1
PMID:3665290
Abstract

The clinical features and additional investigations of 20 Dutch patients suffering from cerebrotendinous xanthomatosis (CTX), an inborn error of metabolism in bile acid synthesis, are described. The onset was in the second or third decade. The clinical picture at the time of examination consisted of a combination of two or more of the following signs: cataract, xanthoma of a tendon, mental deterioration, pyramidal tract signs, cerebellar signs and epilepsy. Mental retardation was reported in patients. CT-scanning showed cerebellar hypodensity in 8 out of 16 patients but this feature did not correlate well with cerebellar signs. The EEG was abnormal in all but one patient. Treatment with chenodeoxycholic acid resulted in a normalization of EEG and biochemical abnormalities but not of the clinical signs. Cholic acid was equally effective but had much less side effects. The importance of a diagnosis in early life is stressed as well as the examination of clinically unaffected heterozygous relatives.

摘要

本文描述了20例患有脑腱性黄瘤病(CTX)的荷兰患者的临床特征及进一步检查情况,CTX是一种胆汁酸合成的先天性代谢缺陷病。发病年龄在二三十岁。检查时的临床表现为以下两种或更多体征的组合:白内障、肌腱黄瘤、智力衰退、锥体束征、小脑体征和癫痫。有患者报告存在智力发育迟缓。CT扫描显示,16例患者中有8例小脑密度减低,但该特征与小脑体征的相关性不佳。除1例患者外,所有患者的脑电图均异常。用鹅去氧胆酸治疗可使脑电图和生化异常恢复正常,但临床体征未改善。胆酸同样有效,但副作用小得多。强调了早期诊断的重要性以及对临床上未受影响的杂合子亲属进行检查的重要性。

相似文献

1
Cerebrotendinous xanthomatosis (CTX): a clinical survey of the patient population in The Netherlands.脑腱黄瘤病(CTX):荷兰患者群体的临床调查
Clin Neurol Neurosurg. 1987;89(3):169-75. doi: 10.1016/s0303-8467(87)80050-1.
2
Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis.
Clin Chim Acta. 1985 Oct 31;152(1-2):115-22. doi: 10.1016/0009-8981(85)90182-2.
3
Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.鹅去氧胆酸对脑腱黄瘤病的长期治疗
N Engl J Med. 1984 Dec 27;311(26):1649-52. doi: 10.1056/NEJM198412273112601.
4
A case of cerebrotendinous xanthomatosis: effects of ursodeoxycholic acid administration on serum bile acids and cholestanol.
Jpn J Med. 1982 Jul;21(3):210-5. doi: 10.2169/internalmedicine1962.21.210.
5
Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis.鹅去氧胆酸和普伐他汀联合治疗可改善脑腱性黄瘤病患者的血浆胆甾烷醇水平,并使肌腱黄瘤明显消退。
Metabolism. 1991 Jul;40(7):741-6. doi: 10.1016/0026-0495(91)90094-d.
6
Biochemical abnormalities in cerebrotendinous xanthomatosis.
Dev Neurosci. 1991;13(4-5):363-70. doi: 10.1159/000112186.
7
Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.脑腱黄瘤病:荷兰患者群体的生化检查结果综述
J Inherit Metab Dis. 1988;11(1):56-75. doi: 10.1007/BF01800057.
8
Computed tomography in cerebrotendinous xanthomatosis.脑腱性黄瘤病的计算机断层扫描
Neurology. 1981 Nov;31(11):1463-5. doi: 10.1212/wnl.31.11.1463.
9
Cerebrotendinous xanthomatosis.
Arch Ophthalmol. 1976 Jan;94(1):148-50. doi: 10.1001/archopht.1976.03910030080018.
10
Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.脑腱黄瘤病中4-胆甾烯-3-酮和7α-羟基-4-胆甾烯-3-酮向胆甾烷醇和胆汁酸的转化
Gastroenterology. 1984 Aug;87(2):276-83.

引用本文的文献

1
Cholic acid as a treatment for cerebrotendinous xanthomatosis: a comprehensive review of safety and efficacy.胆酸治疗脑腱黄瘤病:安全性和有效性的全面综述
Orphanet J Rare Dis. 2025 Jul 29;20(1):387. doi: 10.1186/s13023-025-03889-9.
2
Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.脑腱性黄瘤病:分子发病机制、临床谱、诊断和疾病修饰治疗。
J Atheroscler Thromb. 2021 Sep 1;28(9):905-925. doi: 10.5551/jat.RV17055. Epub 2021 May 8.
3
Cholic acid as a treatment for cerebrotendinous xanthomatosis in adults.
胆酸治疗成人脑腱黄瘤病。
J Neurol. 2019 Aug;266(8):2043-2050. doi: 10.1007/s00415-019-09377-y. Epub 2019 May 21.
4
Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX).脑腱性黄瘤病(CTX)的流行病学、诊断和治疗。
J Inherit Metab Dis. 2017 Nov;40(6):771-781. doi: 10.1007/s10545-017-0093-8. Epub 2017 Oct 4.
5
Psychiatric manifestations in cerebrotendinous xanthomatosis.脑腱黄瘤病的精神表现。
Transl Psychiatry. 2013 Sep 3;3(9):e302. doi: 10.1038/tp.2013.76.
6
Cerebrotendinous xanthomatosis without tendon xanthomas mimicking Marinesco-Sjoegren syndrome: a case report.无肌腱黄瘤的脑腱性黄瘤病酷似 Marinesco-Sjögren 综合征:一例报告
J Neurol Neurosurg Psychiatry. 1996 May;60(5):582-5. doi: 10.1136/jnnp.60.5.582.
7
The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature.脑腱黄瘤病的神经病理学再探讨:一例病例报告及文献综述
Acta Neuropathol. 1995;90(2):213-20. doi: 10.1007/BF00294324.
8
Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.脑腱黄瘤病:荷兰患者群体的生化检查结果综述
J Inherit Metab Dis. 1988;11(1):56-75. doi: 10.1007/BF01800057.
9
Cerebrotendinous xanthomatosis: clinical and MRI study (a case report).脑腱性黄瘤病:临床与磁共振成像研究(病例报告)
J Neurol Neurosurg Psychiatry. 1990 Jan;53(1):76-8. doi: 10.1136/jnnp.53.1.76.
10
Cerebrotendinous xanthomatosis: cranial CT and MRI studies in eight patients.
Neuroradiology. 1992;34(4):308-12. doi: 10.1007/BF00588188.